feed,title,long_url,short_url
SeekingAlpha,IPO Update: Viant Technology Sets Terms For $150 Million IPO,https://seekingalpha.com/article/4403072,
SeekingAlpha,"Neurocrine Sheds Its Parkinson's Gene Therapy Program, While The Street Waits For Ingrezza Reacceleration",https://seekingalpha.com/article/4403059,
